BioCryst Pharmaceuticals Net Profit Margin 2006-2019 | BCRX

BioCryst Pharmaceuticals net profit margin from 2006 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
BioCryst Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-06-30 $0.01B $-0.13B -1145.45%
2019-03-31 $0.02B $-0.11B -481.82%
2018-12-31 $0.02B $-0.10B -505.00%
2018-09-30 $0.02B $-0.09B -447.62%
2018-06-30 $0.03B $-0.08B -272.41%
2018-03-31 $0.02B $-0.08B -390.00%
2017-12-31 $0.03B $-0.07B -264.00%
2017-09-30 $0.03B $-0.05B -170.00%
2017-06-30 $0.03B $-0.05B -165.52%
2017-03-31 $0.03B $-0.05B -151.61%
2016-12-31 $0.03B $-0.06B -207.41%
2016-09-30 $0.02B $-0.07B -300.00%
2016-06-30 $0.03B $-0.07B -276.92%
2016-03-31 $0.05B $-0.05B -108.51%
2015-12-31 $0.05B $-0.04B -87.76%
2015-09-30 $0.05B $-0.04B -75.51%
2015-06-30 $0.04B $-0.03B -75.61%
2015-03-31 $0.02B $-0.05B -318.75%
2014-12-31 $0.01B $-0.05B -383.33%
2014-09-30 $0.02B $-0.04B -216.67%
2014-06-30 $0.02B $-0.04B -223.53%
2014-03-31 $0.02B $-0.04B -205.88%
2013-12-31 $0.02B $-0.03B -166.67%
2013-09-30 $0.01B $-0.04B -327.27%
2013-06-30 $0.02B $-0.04B -253.33%
2013-03-31 $0.02B $-0.04B -211.11%
2012-12-31 $0.03B $-0.04B -150.00%
2012-09-30 $0.03B $-0.04B -151.85%
2012-06-30 $0.03B $-0.05B -173.08%
2012-03-31 $0.03B $-0.05B -188.46%
2011-12-31 $0.02B $-0.06B -294.74%
2011-09-30 $0.03B $-0.05B -170.97%
2011-06-30 $0.04B $-0.05B -131.58%
2011-03-31 $0.04B $-0.04B -104.76%
2010-12-31 $0.06B $-0.03B -53.97%
2010-09-30 $0.10B $-0.01B -8.91%
2010-06-30 $0.10B $-0.01B -9.00%
2010-03-31 $0.10B $-0.01B -8.25%
2009-12-31 $0.08B $-0.01B -18.67%
2009-09-30 $0.05B $-0.02B -35.19%
2009-06-30 $0.05B $-0.02B -32.69%
2009-03-31 $0.05B $-0.02B -42.00%
2008-12-31 $0.06B $-0.03B -43.86%
2008-09-30 $0.05B $-0.04B -72.55%
2008-06-30 $0.06B $-0.04B -62.90%
2008-03-31 $0.07B $-0.03B -45.83%
2007-12-31 $0.07B $-0.03B -41.43%
2007-09-30 $0.04B $-0.04B -84.09%
2007-06-30 $0.03B $-0.04B -161.54%
2007-03-31 $0.02B $-0.05B -300.00%
2006-12-31 $0.01B $-0.04B -628.57%
2006-09-30 $0.01B $-0.04B -820.00%
2006-06-30 $0.00B $-0.03B -1100.00%
2006-03-31 $0.00B $-0.03B -2900.00%
2005-12-31 $0.00B $-0.03B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.296B $0.021B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.530B 37.28
Astellas Pharma (ALPMY) Japan $26.750B 13.12
Takeda Pharmaceutical (TAK) Japan $26.248B 8.20
Grifols, S.A (GRFS) Spain $15.195B 19.39
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.512B 24.95
Merck (MKGAF) Germany $13.654B 18.63
Ionis Pharmaceuticals (IONS) United States $9.835B 21.21
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.041B 0.00
IPSEN SA ADR (IPSEY) France $8.570B 0.00
Sage Therapeutics (SAGE) United States $8.490B 0.00
Catalent (CTLT) United States $8.196B 32.90
Jazz Pharmaceuticals (JAZZ) Ireland $7.686B 10.11
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.894B 17.59
FibroGen (FGEN) United States $3.948B 98.74
United Therapeutics (UTHR) United States $3.588B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.197B 73.30
Taro Pharmaceutical Industries (TARO) Israel $3.174B 11.38
Nektar Therapeutics (NKTR) United States $3.132B 0.00
Evotec AG (EVTCY) Germany $3.127B 42.81
Tilray (TLRY) Canada $2.910B 0.00
PTC Therapeutics (PTCT) United States $2.741B 0.00
Xencor (XNCR) United States $2.298B 50.10
Zogenix (ZGNX) United States $2.161B 0.00
Portola Pharmaceuticals (PTLA) United States $2.046B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.578B 57.42
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.516B 15.20
Corcept Therapeutics (CORT) United States $1.490B 20.48
Enanta Pharmaceuticals (ENTA) United States $1.421B 23.44
Heron Therapeutics (HRTX) United States $1.417B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.405B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.207B 0.00
Aerie Pharmaceuticals (AERI) United States $1.097B 0.00
ArQule (ARQL) United States $1.074B 0.00
Radius Health (RDUS) United States $1.063B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.933B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.855B 3.81
TherapeuticsMD (TXMD) United States $0.680B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.616B 0.00
Endo (ENDP) Ireland $0.577B 1.02
Akebia Therapeutics (AKBA) United States $0.574B 0.00
Karyopharm Therapeutics (KPTI) United States $0.572B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.545B 0.00
Concordia (CXRXF) Canada $0.533B 0.00
Indivior (INVVY) United States $0.520B 1.88
Aptorum Group (APM) China $0.467B 0.00
Dermira (DERM) United States $0.466B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.460B 0.00
Organogenesis Holdings (ORGO) United States $0.453B 0.00
Dova Pharmaceuticals (DOVA) United States $0.435B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.432B 19.67
ImmunoGen (IMGN) United States $0.427B 0.00
Flexion Therapeutics (FLXN) United States $0.418B 0.00
Translate Bio (TBIO) United States $0.415B 0.00
Siga Technologies (SIGA) United States $0.412B 0.96
ChemoCentryx (CCXI) United States $0.412B 0.00
Collegium Pharmaceutical (COLL) United States $0.389B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.370B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.334B 0.00
Xeris Pharmaceuticals (XERS) United States $0.315B 0.00
CV Sciences (CVSI) United States $0.314B 0.00
KalVista Pharmaceuticals (KALV) United States $0.288B 0.00
CannTrust Holdings (CTST) Canada $0.286B 0.00
Harpoon Therapeutics (HARP) United States $0.285B 0.00
Rafael Holdings (RFL) United States $0.276B 0.00
Lannett Co Inc (LCI) United States $0.272B 2.64
La Jolla Pharmaceutical (LJPC) United States $0.270B 0.00
OptiNose (OPTN) United States $0.269B 0.00
DURECT (DRRX) United States $0.261B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.258B 0.00
Recro Pharma (REPH) United States $0.253B 0.00
Concert Pharmaceuticals (CNCE) United States $0.252B 0.00
Calithera Biosciences (CALA) United States $0.220B 0.00
Ocular Therapeutix (OCUL) United States $0.217B 0.00
Molecular Templates (MTEM) United States $0.188B 0.00
Ardelyx (ARDX) United States $0.187B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.185B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 29.48
Taiwan Liposome (TLC) Taiwan $0.171B 0.00
Redhill Biopharma (RDHL) Israel $0.152B 0.00
IMV INC (IMV) Canada $0.151B 0.00
GlycoMimetics (GLYC) United States $0.151B 0.00
Generex Biotechnology (GNBT) United States $0.138B 0.00
Majesco Entertainment (PTE) United States $0.134B 0.00
Jounce Therapeutics (JNCE) United States $0.127B 0.00
MEI Pharma (MEIP) United States $0.125B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.125B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.121B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.111B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.104B 0.00
AgeX Therapeutics (AGE) United States $0.103B 0.00
Cardiome Pharma (CORV) Canada $0.101B 0.00
Iterum Therapeutics (ITRM) Ireland $0.096B 0.00
Mast Therapeutics (SVRA) United States $0.096B 0.00
Neos Therapeutics (NEOS) United States $0.093B 0.00
Aquestive Therapeutics (AQST) United States $0.093B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 31.82
MediWound (MDWD) Israel $0.082B 0.00
Genocea Biosciences (GNCA) United States $0.081B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.076B 0.00
Natural Alternatives (NAII) United States $0.075B 7.52
China SXT Pharmaceuticals (SXTC) China $0.072B 0.00
Otonomy (OTIC) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.068B 584.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Novan (NOVN) United States $0.065B 0.00
Capnia (SLNO) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
SCYNEXIS (SCYX) United States $0.060B 0.00
Lipocine (LPCN) United States $0.059B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.043B 0.00
India Globalization Capital (IGC) United States $0.042B 0.00
CTI BioPharma (CTIC) United States $0.039B 0.00
Aclaris Therapeutics (ACRS) United States $0.038B 0.00
Melinta Therapeutics (MLNT) United States $0.037B 0.00
Bio-Path Holdings (BPTH) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
PharmAthene (ALT) United States $0.034B 0.00
Biomerica (BMRA) United States $0.030B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Opexa Therapeutics (ACER) United States $0.022B 0.00
IsoRay (ISR) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.43
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
Achieve Life Sciences (ACHV) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00